Blume Capital Management’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$54.2K Buy
846
+6
+0.7% +$394 0.01% 200
2026
Q1
$59.8K Hold
840
0.01% 180
2025
Q4
$68.9K Hold
840
0.01% 168
2025
Q3
$63.1K Hold
840
0.01% 180
2025
Q2
$62.2K Hold
840
0.01% 176
2025
Q1
$67.8K Hold
840
0.02% 165
2024
Q4
$65.7K Hold
840
0.01% 171
2024
Q3
$78.8K Sell
840
-125
-13% -$10.5K 0.02% 161
2024
Q2
$75.2K Hold
965
0.02% 156
2024
Q1
$87.7K Hold
965
0.02% 152
2023
Q4
$74.6K Hold
965
0.02% 153
2023
Q3
$65.7K Hold
965
0.02% 155
2023
Q2
$78.4K Hold
965
0.02% 145
2023
Q1
$79.2K Buy
+965
New +$68.9K 0.03% 140

Other funds holding GEHC

Blume Capital Management's GEHC Position: Q2 2026 in Review

Blume Capital Management increased its GE HealthCare (GEHC) stake by 0.71% in Q2 2026, buying an estimated $394 and bringing the position to 846 shares worth $54.2K. The position accounts for 0.01% of the portfolio, ranked #200.

Blume Capital Management first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $87.7K in Q1 2024. 570 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Blume Capital Management held 846 shares of GE HealthCare worth $54.2K as of Q2 2026.
  • Blume Capital Management bought 6 GE HealthCare shares in Q2 2026, an estimated $394.
  • GE HealthCare made up 0.01% of Blume Capital Management's portfolio in Q2 2026, its #200 holding.
  • Blume Capital Management first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
  • Blume Capital Management's GE HealthCare position peaked at $87.7K in Q1 2024.
  • 570 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Blume Capital Management's 13F filing for Q2 2026, filed 27 Jul 2026.